Neuronetics (STIM)
(Delayed Data from NSDQ)
$3.49 USD
-0.03 (-0.85%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.50 +0.01 (0.29%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for Neuronetics, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 71 | 65 | 55 | 49 | 63 |
Cost Of Goods | 20 | 15 | 12 | 12 | 15 |
Gross Profit | 52 | 50 | 44 | 38 | 47 |
Selling & Adminstrative & Depr. & Amort Expenses | 82 | 85 | 71 | 60 | 74 |
Income After Depreciation & Amortization | -31 | -35 | -28 | -22 | -27 |
Non-Operating Income | 6 | 2 | 0 | -1 | 2 |
Interest Expense | 5 | 4 | 4 | 5 | 4 |
Pretax Income | -30 | -37 | -31 | -27 | -29 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -30 | -37 | -31 | -27 | -29 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -30 | -37 | -31 | -27 | -29 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -29 | -33 | -27 | -21 | -26 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -31 | -35 | -28 | -22 | -27 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 28.66 | 26.90 | 25.48 | 18.84 | 18.38 |
Diluted EPS Before Non-Recurring Items | -1.05 | -1.38 | -1.22 | -1.41 | -1.58 |
Diluted Net EPS (GAAP) | -1.05 | -1.38 | -1.22 | -1.46 | -1.58 |
Fiscal Year end for Neuronetics, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 20.31 | 17.88 | 17.61 | 15.54 |
Cost Of Goods | NA | 4.54 | 6.12 | 4.84 | 4.14 |
Gross Profit | NA | 15.77 | 11.76 | 12.77 | 11.40 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 20.20 | 20.64 | 20.12 | 21.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -4.43 | -8.88 | -7.35 | -9.90 |
Non-Operating Income | NA | 0.89 | 0.66 | 3.59 | 0.64 |
Interest Expense | NA | 1.84 | 1.18 | 1.14 | 1.25 |
Pretax Income | NA | -5.38 | -9.39 | -4.90 | -10.52 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.38 | -9.39 | -4.90 | -10.52 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.38 | -9.39 | -4.90 | -10.52 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 29.05 | 28.88 | 28.59 | 28.03 |
Diluted EPS Before Non-Recurring Items | NA | -0.19 | -0.33 | -0.17 | -0.38 |
Diluted Net EPS (GAAP) | NA | -0.17 | -0.33 | -0.17 | -0.38 |